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Purpose: To describe the first instance of genotyping in a Latin American family with Wolfram syndrome (WS).
Methods: Four affected siblings and their healthy parents were studied. Ophthalmologic examination included best
corrected visual acuity determination, funduscopy, fluorescein retinal angiography, and Goldmann kinetic perimetry.
Molecular methods included linkage analysis using microsatellites markers located on the markers located on the Wofram
syndrome 1 (WFS1) region at 4p16.1, PCR amplification and direct nucleotide sequencing analysis of the complete coding
region and exon/intron junctions of WFS1. In addition, allele-specific cloning and sequencing techniques were used to
characterize a heterozygous frameshift mutation.
Results: The four affected siblings presented with a homogeneous clinical picture characterized by early onset diabetes
mellitus, severe optic atrophy, and progressive hearing loss. Linkage analysis indicated that all four sibs were heterozygous
for markers linked to the WFS1 region and that each inherited the same allele from the mother and the same from the
father, suggesting compound heterozygosity. Direct WFS1 analysis disclosed a paternally inherited novel missense R177P
mutation whereas allele-specific cloning and sequencing revealed a novel WFS1 16 bp deletion that was inherited from
the mother.
Conclusions: Our report of two novel WFS1 mutations expands the molecular spectrum of Wolfram syndrome. This is
the first documented case of the molecular basis of the disease in a Latin American family. Analysis of more patients from
this population will establish if compound heterozygosity is commonly found in affected individuals from this ethnic
group.
Wolfram  syndrome  (WS;  OMIM  222300)  is  an
uncommon genetic disease defined by the association of early
onset  optic  atrophy  and  diabetes  mellitus,  both  appearing
during the first two decades of life [1]. The disease is inherited
as an autosomal recessive trait with an estimated prevalence
of 1 in 770,000 and an estimated carrier frequency of 1 in 354;
both figures are derived from a United Kingdom nationwide
study of the syndrome [2]. WS is considered as a progressive
neurodegenerative disorder that can include ataxia, peripheral
neuropathy,  urinary-tract  atony,  sensorineural  hearing
impairment, and psychiatric manifestations (reviewed in [3]].
WS  is  also  known  as  DIDMOAD  for  diabetes  insipidus,
diabetes mellitus, optic atrophy, and deafness [4]. Brainstem
atrophy frequently leads to central respiratory failure, which
is the most common cause of death in WS individuals, usually
during the fourth decade of life [2]. Other associated clinical
findings in WS include gastrointestinal disorders, such as
dismotility (constipation as well as chronic diarrhea), urinary
incontinence,  recurrent  urinary  infections,  hidronephrosis,
primary gonadal atrophy (males), and menstrual irregularities
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and delayed menarche [3,5]. Although there is considerable
individual variation in clinical signs, the minimal diagnostic
criteria are the concurrence of early onset (<15 years) diabetes
mellitus, and progressive optic atrophy. These criteria give a
positive  predictive  value  for  WS  of  83%  and  a  negative
predictive value of 1% [2].
WS is caused by homozygous mutations in WFS1, a gene
located at 4p16.1 and composed of seven coding exons [6,7].
WFS1 encodes wolframin, an 890 amino acid glycoprotein
that  localizes  primarily  in  the  endoplasmic  reticulum  [8],
where it has been shown to participate in the regulation of
cellular calcium homeostasis [9]. To date, approximately 130
distinct  mutations  in  WFS1  have  been  identified  in  WS
individuals  from  different  ethnic  backgrounds,  and  these
include  a  variety  of  missense,  nonsense,  and  frameshift
insertion/deletion mutations [4,6,7,10-15]. Deleterious WFS1
changes are distributed along the entire gene without apparent
mutational hot spots.
The  aim  of  this  study  is  to  describe  the  clinical  and
molecular features of an unusual WFS family composed by
four affected sons of a non-consanguineous marriage. This is
the first description of the molecular basis of WS in a Latin
American  family,  and  our  results  add  to  the  genotypic
spectrum of the disease.
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Figure  1.  Funduscopic  appearance  of  patients  with  Wolfram
syndrome. Shown are fundus photographs from (A) 19-year-old case
1 (OD) and from (B) 14-year-old case 3 (OS). Both photographs
reveal severe waxy pallor of the optic disc.
conserved in the right eye of 90x20 degrees and in the left eye
of 60x10 degrees. FAG was normal in both eyes. Audiometric
test showed low-frequency hearing loss. Dental examination
showed enamel hypoplasia and abnormal coloration of teeth
Case 3: This was a 14-year-old male, who was given a
diagnosis of diabetes mellitus type 1 when he was 7 years old.
He had a history of a surgical correction of a tracheoesophagic
fistula at the age of 8 months. He presented with a history of
decreased visual acuity. At ophthalmologic examination, his
visual acuity was 20/100 in both eyes. Pupils were mydriatic
with decreased light reflex. Optic nerve head cup to disc ratio
was 0.25 in both eyes, and both optic discs showed severe
pallor (Figure 1B). GKP and FAG were normal in both eyes.
Audiometry  showed  low-frequency  hearing  loss.  Dental
examination  showed  enamel  alterations  and  teeth
discoloration.
Case  4:  The  youngest  brother  was  11  years  old.  He
received a diagnosis of diabetes mellitus type 1 when he was
5 years old. In the right eye, he had a visual acuity of 20/300
that improved to 20/200, and in the left eye, it was 20/400 that
improved to 20/300. Pupils were mydriatic with decreased
light reflex. Both optic nerve heads had a cup to disc ratio of
0.25  and  exhibited  severe  pallor.  In  addition,  pigmentary
changes were observed in the macular area, bilaterally. GKP
showed concentric reduction of 30 degrees and an enlarged
blind spot. FAG was normal for both eyes. Audiometric tests
revealed  low-frequency  hearing  loss.  Dental  examination
showed enamel alterations and changes in teeth coloration.
Linkage  analysis:  DNA  was  isolated  from  peripheral
blood leukocytes by standard procedures. Four microsatellite
DNA markers (D4S432, D4S3023, D4S2366, and D4S2639)
linked to the WFS1 locus on 4p16.1 were used to determine
linkage  in  the  family  [16].  Microsatellite  analysis  was
performed  in  an  ABI  310  Genetic  Analyzer  (Applied
Biosystems, Foster City, CA) using the GenScan software
(Applied Biosystems) for amplicon size determination.
WFS1  mutational  analysis:  The  entire  WFS1  coding
sequence (seven coding exons), as well as the intron/exon
junctions, were amplified by PCR in DNA from the four
affected patients and their parents using temperatures and
primers available upon request. Each 25 μl PCR amplification
reaction contained 1X buffer (20 μM Tris-Cl, 100 μM KCl, 0.1
μM EDTA, and 0.5% (v/v) Tween 20), 200 ng of genomic
DNA, 0.2 mM of each dNTP, 2U Taq polymerase, 1 mM of
forward and reverse primers (Table 1), and 1.5 mM MgCl2.
PCR products were analyzed in 1.5% agarose gels from which
the bands with the amplified templates were excised, and the
DNA subsequently purified with the help of the Qiaex II kit
(Qiagen, Hilden, Germany). Direct automated sequencing of
WFS1  was  performed  with  the  BigDye  Terminator  Cycle
Sequencing  kit  (Applied  Biosystems,  Foster  City,  CA),
adding about 15 ng of template DNA in each reaction and
using  a  temperature  program  that  included  25  cycles  of
Molecular Vision 2008; 14:1353-1357 <http://www.molvis.org/molvis/v14/a163> © 2008 Molecular Vision 1354denaturation at 97 °C for 30 s, annealing at 50 °C for 15 s, and
extension at 60 °C for 4 min. Samples were analyzed in an
ABI  Prism  310  Genetic  Analyzer  (Applied  Biosystems).
Wild-type  and  mutated  WFS1  sequences  were  compared
manually.
WFS1 allele-specific cloning and sequencing: An allele-
specific  cloning  and  sequencing  approach  was  used  to
precisely characterize a WFS1 frameshift mutation. Briefly,
new WFS1 exon 8 products were amplified from genomic
DNA, gel-purified, ligated by means of a TA-ligation method
into  the  TA-cloning  vector  pGEM-T  (Promega,  Madison,
WI),  and  subcloned  into  DH5α  E.  coli  competent  cells
(Invitrogen, Carlsbad, CA) using standard procedures. The
plasmid  inserts  were  sequenced  with  the  aforedescribed
protocol and using the forward pUC/M13 primer. DNA from
four  independent  clones  was  sequenced.  Wild-type  and
mutated sequences were compared manually.
RESULTS
The clinical association of early onset diabetes mellitus and
progressive optic atrophy suggested the diagnosis of WS in
the four affected siblings from this family. As a first screening
analysis, we performed linkage analysis to the WFS1 locus at
4p16.1  by  means  of  genotyping  of  markers  D4S432,
D4S3023, DS2366, and D4S2639. Visual inspection of the
haplotypes  revealed  that  all  four  affected  siblings  were
heterozygous for the four markers as each parent consistently
transmitted to their progeny the same WFS1-linked haplotype
(Figure 2). These results strongly suggested WFS1 compound
heterozygosity  as  the  source  of  the  disease.  Nucleotide
sequencing of the entire WFS1 coding region confirmed the
presence  of  two  different  mutations  in  the  four  affected
patients: one allele carried a novel R177P missense mutation
resulting from a G>C transversion at nucleotide position 530
in exon 5 (Figure 3). This missense mutation was present
TABLE 1.  OLIGONUCLEOTIDE   SEQUENCES   USED   FOR  PCR  AMPLIFICATION AND  
DIRECT
 
AUTOMATED
 
NUCLOTIDE SEQUENCING   OF   WFS1   IN THIS   STUDY.
Exon Primers (5’-3’) Tm °C
2 F: GCAGACACTAAGTGCCAGA 56
R: CTGAACTGCAGAGGACCTG
3 F: GCAGCAGCAGATCTGAAGA 56.6
R: TCTCAGGCACCGACACTTCT
4 F: GAAGTGGGTGAAAGGAGGT 53.9
R: CAGTTAGCAAGCAGCATTAC
5-6 F: GTCAGAGTGGCACCGAAAGC 65.1
R: TCGCCCTGCAGGTGCAGGCTGGGA
7 F: ATTGCTCTGTGTGAGGGTG 62.8
R: CCTGCCTGAGGTGCGCGAGT
8-1 F: TTGCCCAGAGGCAGGGTGGT 61.3
R: ATGGAGGGCAGCAGCGATAGCA
8-2 F: ATCCCCTGCTCGGAGCTGGCT 63
R: AGTTGTAGACCTTCATGCC
8-3 F: CAAGGCCAGCTTCTCTGTGGT 59.1
R: ATGGCCTTGAGCTCGAAGACA
8-4 F: CAAGGACATCGTGCTGCGGGC 63
R: AGTCTGCACACGTGGGCACA
Annealing temperature as are indicated at right. In this table
(F) is forward primer, (R) is reverse primer.
heterozygously also in DNA from the father. Exon 8 DNA
from  the  four  affected  siblings  exhibited  an  overlapping
pattern  on  automated  DNA  sequencing  indicating  the
presence of a frameshift mutation. Allele-specific sequencing
of a fragment of exon 8 allowed the identification of a novel
16 bp deletion, 1355–1370delAGC CCT ACA CGC GCA G
(c.1354del16), that predicts the introduction of a premature
stop signal 65 codons downstream, P451fsX515 (Figure 4).
Maternal DNA analysis demonstrated that the mother carried
this 16 bp deletion in a heterozygous state.
DISCUSSION
WS is an autosomal recessive disorder characterized by the
association  of  juvenile-onset  diabetes  mellitus  and  optic
atrophy. The disease is caused by homozygous mutations in
the gene WFS1 at 4p16.1. A second form of WS, WFS2, maps
to 4q22-q25 [16] and has been recently demonstrated to be
caused by homozygous mutations in a highly conserved zinc-
finger gene, ZCD2 [17]. Similar to Wolframin, ERIS, the
ZCD2  encoded  protein,  also  localizes  to  the  endoplasmic
reticulum [17].
Molecular defects in WS1 are associated with non-WS
phenotypes.  Heterozygous  mutations  in  WFS1  have  been
demonstrated  to  be  a  cause  of  dominantly  inherited
nonsyndromic  low-frequency  sensorineural  hearing  loss
[18].  Moreover,  an  association  between  WFS1  single
nucleotide polymorphisms and an increased risk of type 2
diabetes has been identified in European populations [19,20].
Figure 2. Linkage analysis for Wolfram syndrome locus markers at
4p16.1. Filled squares denote affected individuals. All four siblings
inherited the same haplotype from their father (blue) and the same
haplotype  (red)  from  their  mother,  which  suggested  compound
heterozygosity.
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1355This is supported by the previous observation of an increased
prevalence of diabetes mellitus in first-degree relatives of WS
patients  [21].  Similarly,  heterozygous  carriers  of  WFS1
mutations  have  an  increased  incidence  of  psychiatric
disorders including endogenous depression, suicide attempts,
short-term memory loss, and anxiety [22].
In this work we have described the clinical and molecular
features of four Mexican siblings who have WS. To the best
of our knowledge, this is the first Latin American WS family
Figure 3. WFS1 gene novel point mutation in WS. Exon 5 sequence
analysis  in  DNA  from  an  affected  subject  (case  1)  revealed  a
heterozygous change from wild type guanine (A) to cytosine (B),
predicting  the  change  of  arginine  (CGC)  to  proline  (CCC)  in
Wolframin residue 177.
Figure 4. WFS1 gene novel frameshift mutation in WS. Exon 8
sequence analysis revealed that a normal tract of 16 bp (boxed in A)
is heterozygously deleted in DNA from an affected subject (case 1)
(B). The deletion predicts the introduction of a premature stop signal
65 codons downstream residue 451 of Wolframin.
in which the molecular basis of the disease has been analyzed.
This family was unusual as all the four descendants of a non-
consanguineous couple were affected. The parents were not
relatives,  originated  from  distant  geographic  areas  of  the
country, and each of them was a heterozygous carrier for a
different  WFS1  mutation.  WFS  prevalence  or  carrier
frequencies  in  Mexico  are  currently  unknown.  A  carrier
frequency of 1 in 354 was estimated by Barret et al. [2]. in the
United Kingdom.
Although compound heterozygosity for WFS has been
previously  reported  [14,15,23],  the  present  pedigree  is  an
unusual compound heterozygosity familial example as the
four sons of this unrelated couple inherited a mutated allele
from each parent and were affected. This greatly deviates from
the empiric 25% risk of autosomal recessive diseases.
Genetic analysis revealed that affected members of this
family were compound heterozygous for two novel WFS1
mutations, including a paternally inherited missense mutation
at exon 5 and a maternally inherited 16 bp deletion at exon 8.
The missense mutation at exon 5 replaces an arginine residue
at position 177 in the Wolframin extracellular 1 domain, while
the 16 bp deletion predicts a frameshift from amino acid 451,
in the transmembrane 4 domain, and the introduction of a
premature stop codon 65 residues downstream. An arginine
residue at position 177 is evolutionarily conserved among
Wolframin proteins in several species, indicating its biologic
significance.
Besides  the  typical  features  of  WS,  all  four  patients
exhibited  a  homogeneous  pattern  of  dental  anomalies
characterized by enamel hyoplasia and abnormalities in teeth
color. To the best of our knowledge, dental anomalies have
not  been  reported  as  being  associated  with  WS  and  it  is
unknown to us if dental anomalies in this family were related
to the specific WFS1 compound mutation.
In conclusion, our study analyzes for the first time the
WFS1 gene status in a Latin American family with WS and
adds to the mutational spectrum of the disease. Molecular
investigation  of  more  samples  of  WS  patients  from  our
country  will  help  to  identify  if  compound  heterozygosity
occurs commonly or if there are recurrent or founder WFS1
mutations in this particular ethnic group.
ACKNOWLEDGMENTS
The authors thank Dr. Patricia Roa-Perez for performing the
dental  examinations,  and  Reyna  Martinez,  from  Hospital
General de México for performing the audiometric tests.
REFERENCES
1. Wolfram DJ, Wagener HP. Diabetes mellitus and simple optic
atrophy among siblings: report of four cases. Mayo Clin Proc
1938; 13:715-8.
2. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and
diabetes: UK nationwide study of Wolfram (DIDMOAD)
syndrome. Lancet 1995; 346:1458-63. [PMID: 7490992]
Molecular Vision 2008; 14:1353-1357 <http://www.molvis.org/molvis/v14/a163> © 2008 Molecular Vision
13563. Minton JA, Rainbow LA, Ricketts C, Barrett TG. Wolfram
syndrome. Rev Endocr Metab Disord 2003; 4:53-9. [PMID:
12618560]
4. Khanim  F,  Kirk  J,  Latif  F,  Barrett  TG.  WFS1/Wolframin
mutations, Wolfram syndrome, and associated diseases. Hum
Mutat 2001; 17:357-67. [PMID: 11317350]
5. Bitoun P. Wolfram syndrome. A report of four cases and review
of the literature. Ophthalmic Genet 1994; 15:77-85. [PMID:
7850272]
6. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-
Mizrachi E, Mueckler M, Marshall H, Donis-Keller H, Crock
P, Rogers D, Mikuni M, Kumashiro H, Higashi K, Sobue G,
Oka  Y,  Permutt  MA.  A  gene  encoding  a  transmembrane
protein is mutated in patients with diabetes mellitus and optic
atrophy (Wolfram syndrome). Nat Genet 1998; 20:143-8.
[PMID: 9771706]
7. Strom TM, Hörtnagel K, Hofmann S, Gekeler F, Scharfe C,
Rabl  W,  Gerbitz  KD,  Meitinger  T.  Diabetes  insipidus,
diabetes mellitus, optic atrophy and deafness (DIDMOAD)
caused by mutations in a novel gene (wolframin) coding for
a predicted transmembrane protein. Hum Mol Genet 1998;
7:2021-8. [PMID: 9817917]
8. Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, Watanabe
Y, Shinoda K, Oka Y. WFS1 (Wolfram syndrome 1) gene
product: predominant subcellular localization to endoplasmic
reticulum in cultured cells and neuronal expression in rat
brain. Hum Mol Genet 2001; 10:477-84. [PMID: 11181571]
9. Takei D, Ishihara H, Yamaguchi S, Yamada T, Tamura A,
Katagiri H, Maruyama Y, Oka Y. WFS1 protein modulates
the free Ca(2+) concentration in the endoplasmic reticulum.
FEBS Lett 2006; 580:5635-40. [PMID: 16989814]
10. Hardy  C,  Khanim  F,  Torres  R,  Scott-Brown  M,  Seller  A,
Poulton J, Collier D, Kirk J, Polymeropoulos M, Latif F,
Barrett  T.  Clinical  and  molecular  genetic  analysis  of  19
Wolfram syndrome kindreds demostrating a wide spectrum
of mutations in WFS1. Am J Hum Genet 1999; 65:1279-90.
[PMID: 10521293]
11. Gómez-Zaera M, Strom TM, Rodríguez B, Estivill X, Meitinger
T, Nunes V. Presence of a major WFS1 mutation in Spanish
Wolfram  syndrome  pedigrees.  Mol  Genet  Metab  2001;
72:72-81. [PMID: 11161832]
12. Tessa A, Carbone I, Matteoli MC, Bruno C, Patrono C, Patera
IP, De Luca F, Lorini R, Santorelli FM. Identification of novel
WFS1 mutations in Italian children with Wolfram syndrome.
Hum Mutat 2001; 17:348-9. [PMID: 11295831]
13. Cryns K, Sivakumaran TA, Van den Ouweland JMW, Pennings
RJE, Cremers CWRJ, Flothmann K, Young T-L, Smith RJH,
Lesperance MM, Van Camp G. Mutational spectrum of the
WFS1 gene in Wolfram syndrome, nonsyndromic hearing
impairment, diabetes mellitus, and psychiatric disease. Hum
Mutat 2003; 22:275-87. [PMID: 12955714]
14. Hansen  L,  Eiberg  H,  Barrett  T,  Bek  T,  Kjaersgaard  P,
Tranebjaerg L, Rosenberg T. Mutation analysis of the WFS1
gene in seven Danish Wolfram syndrome families; four new
mutations identified. Eur J Hum Genet 2005; 13:1275-84.
[PMID: 16151413]
15. Giuliano  F,  Bannwarth  S,  Monnot  S,  Cano  A,  Chabrol  B,
Vialettes B, Delobel B, Paquis-Flucklinger V. French Group
of  WS.  Wolfram  syndrome  in  French  population:
characterization of novel mutations and polymorphisms in the
WFS1  gene.  Hum  Mutat  2005;  25:99-100.  [PMID:
15605410]
16. El-Shanti  H,  Lidral  AC,  Jarrah  N,  Druhan  L,  Ajlouni  K.
Homozygosity  mapping  identifies  an  additional  locus  for
Wolfram syndrome on chromosome 4q. Am J Hum Genet
2000; 66:1229-36. [PMID: 10739754]
17. Amr S, Heisey C, Zhang M, Xia XJ, Shows KH, Ajlouni K,
Pandya A, Satin LS, El-Shanti H, Shiang R. A homozygous
mutation in a novel zinc-finger protein, ERIS, is responsible
for  Wolfram  syndrome  2.  Am  J  Hum  Genet  2007;
81:673-83. [PMID: 17846994]
18. Bespalova IN, Van Camp G, Bom SJ, Brown DJ, Cryns K,
DeWan AT, Erson AE, Flothmann K, Kunst HP, Kurnool P,
Sivakumaran TA, Cremers CW, Leal SM, Burmeister M,
Lesperance MM. Mutations in the Wolfram syndrome 1 gene
(WFS1) are a common cause of low frequency sensorineural
hearing  loss.  Hum  Mol  Genet  2001;  10:2501-8.  [PMID:
11709537]
19. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham
SL, Daly A, Lango H, Frayling TM, Neumann RJ, Sherva R,
Blech I, Pharoah PD, Palmer CN, Kimber C, Tavendale R,
Morris AD, McCarthy MI, Walker M, Hitman G, Glaser B,
Permutt  MA,  Hattersley  AT,  Wareham  NJ,  Barroso  I.
Common variants in WFS1 confer risk of type 2 diabetes. Nat
Genet 2007; 39:951-3. [PMID: 17603484]
20. Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne
F,  Dina  C,  Froguel  P,  Mohlke  KL,  Willer  C,  Olsson  T,
Wareham  NJ,  Hallmans  G,  Barroso  I,  Sandhu  MS.
Replication of the association between variants in WFS1 and
risk of type 2 diabetes in European populations. Diabetologia
2008; 51:458-63. [PMID: 18040659]
21. Fraser FC, Gunn T. Diabetes mellitus, diabetes insipidus, and
optic  atrophy.  An  autosomal  recessive  syndrome?  J  Med
Genet 1977; 14:190-3. [PMID: 881709]
22. Swift  RG,  Polymeropoulos  MH,  Torres  R,  Swift  M.
Predisposition  of  Wolfram  syndrome  heterozygotes  to
psychiatric illness. Mol Psychiatry 1998; 3:86-91. [PMID:
9491819]
23. Van Den Ouweland JMW, Cryns K, Pennings RJ, Walraven I,
Janssen GM, Maassen JA, Veldhuijzen BF, Arntzenius AB,
Lindhout D, Cremers CW, Van Camp G, Dikkeschei LD.
Molecular  characterization  of  WFS1  in  patients  with
Wolfram syndrome. J Mol Diagn 2003; 5:88-95. [PMID:
12707373]
Molecular Vision 2008; 14:1353-1357 <http://www.molvis.org/molvis/v14/a163> © 2008 Molecular Vision
The print version of this article was created on 21 July 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1357